Article (Scientific journals)
Indications cliniques de la radiotherapie metabolique dans les lymphomes
Witvrouw, Nancy; De Prijck, Bernard; Hustinx, Roland
2008In Revue Médicale Suisse, 4 (168), p. 1818-22
Peer Reviewed verified by ORBi
 

Files


Full Text
Witvrouw N et al, Rev Med Suisse 2008.pdf
Publisher postprint (552.92 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Antibodies, Monoclonal/therapeutic use; Humans; Lymphoma/radiotherapy; Radioimmunotherapy/methods
Abstract :
[en] In their later stages low grade lymphoma are incurable. These lymphomas being radio-sensitive, a treatment of metabolic radioimmunotherapy, using monoclonal antibodies (anti-CD20) as the carrier has been developed. The aim of this treatment is to use these antibodies to target radiation to tumor tissues while limiting toxicity to normal cells. Ibritumomab tiuxetan (Zevalin) is currently prescribed for patients with relapsed or refractory low-grade follicular lymphoma after rituximab treatment. This outpatient treatment has a high level of overall response rate including complete response and that for a long period. The side effects are essentially hematological and reversible. In the near future many more indications should become apparent and Zevalin should become an important tool in the B-cell lymphoma (low and high grade).
Disciplines :
Oncology
Author, co-author :
Witvrouw, Nancy ;  Centre Hospitalier Universitaire de Liège - CHU > Médecine nucléaire
De Prijck, Bernard ;  Centre Hospitalier Universitaire de Liège - CHU > Hématologie clinique
Hustinx, Roland  ;  Centre Hospitalier Universitaire de Liège - CHU > Médecine nucléaire
Language :
French
Title :
Indications cliniques de la radiotherapie metabolique dans les lymphomes
Alternative titles :
[en] Clinical indications of radioimmunotherapy in lymphoma
Publication date :
2008
Journal title :
Revue Médicale Suisse
ISSN :
1660-9379
Publisher :
Medecine et Hygiène, Switzerland
Volume :
4
Issue :
168
Pages :
1818-22
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 14 April 2009

Statistics


Number of views
124 (4 by ULiège)
Number of downloads
1 (0 by ULiège)

Scopus citations®
 
0
Scopus citations®
without self-citations
0

Bibliography


Similar publications



Contact ORBi